Advertisement
Jiangxi Leading Group Office issued an ordinance of qualified candidates for the 'National Essential Drug List'; and Jiangxi RongYu product, the 'Yuan Hu Zhi Tong Capsule' had been added to this List. As by the decree of the Ministries of Finance and of Health, all medicines placed on this list must be available to doctors and in stock with pharmacies and county hospitals. The government health plan also fully covers and reimburses the patients for the use of this medicine.
Advertisement
Being placed on this list and the fact that the medical authorities are required by law to carry this medicine increases Jiangxi RongYu Pharmaceutical Group's sales and marketing efficiency, while significantly reducing marketing and distribution costs for this product.
'Yuan Hu Zhi Tong Capsule' or 'Yuan Hu Zhi Tong Pian' is a traditional formula for alleviating pain, including headaches, menstrual discomfort, liver or gallbladder problems, angina and muscle spasms.
In other company events, the company has today filed its up to date Adequate Disclosure with Pink Sheets. Also in addition to the Adequate Disclosure the company has also filed certain industry research reports with The Pink Sheets for the company followers review.
Hiru Corporation is a parent company of China based pharmaceutical company - Jiangxi RongYu Pharmaceutical Group, Inc. Hiru opens its way to become a multinational player with substantial operations and revenues. Jiangxi RongYu Pharmaceutical Group, Inc. (http://www.jxrongyuyy.com/) is strong and strategically-balanced Pharmaceutical Co with plans to enter international trade markets, expand and deliver the expanding product lines worldwide.
To be included in HIRU's email database for press releases and industry updates, please subscribe at or opt in with your email address at this link http://www.minamargroup.com/updates/.
Safe Harbor Statement
Information in this news release may contain statements about future expectations, plans, prospects or performance of Hiru Corporation that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project" and similar words and phrases are intended to identify such forward-looking statements. Hiru Corporation cautions you that any forward-looking information provided by or on behalf of Hiru Corporation is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Hiru Corporation's actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hiru Corporation's control. In addition to those discussed in Hiru Corporation's press releases, public filings, and statements by Hiru Corporation's management, including, but not limited to, Hiru Corporation's estimate of the sufficiency of its existing capital resources, Hiru Corporation's ability to raise additional capital to fund future operations, Hiru Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Hiru Corporation's capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hiru Corporation does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
CONTACT: Hiru Corporation, www.minamargroup.net/helpdesk, Ph (647) 426-1640
SOURCE Hiru Corporation
